3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 2
2
Phase 4
1
Phase 3
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
374
Neoplasms
325
Neoplasm Metastasis
289
Leukemia, Myeloid, Acute
282
Breast Neoplasms
276
Colorectal Neoplasms
238
Melanoma
196
Ovarian Neoplasms
192
Recurrence
185
Multiple Myeloma
180
Prostatic Neoplasms
157
Pancreatic Neoplasms
156
Lung Neoplasms
156
Squamous Cell Carcinoma of Head and Neck
150
Lymphoma, Non-Hodgkin
145
Glioblastoma
145
Triple Negative Breast Neoplasms
119
Myelodysplastic Syndromes
117
Carcinoma, Renal Cell
111
Stomach Neoplasms
110
Advanced Solid Tumors
108
Glioma
107
Precursor Cell Lymphoblastic Leukemia-Lymphoma
104
Brain Neoplasms
104
Lymphoma
103
Lymphoma, Large B-Cell, Diffuse
102
Lymphoma, B-Cell
98
Carcinoma, Hepatocellular
95
Endometrial Neoplasms
92
Lymphoma, Follicular
90
Interventions
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Urogenital Diseases
×
1 year
×
Clear all
NCT07103018
2026-03-23
STRIKE-001
K36 Therapeutics, Inc.
Phase 1
Recruiting
144 enrolled